307 filings
Page 4 of 16
8-K
xfo3ll fvnyegn5ieje
14 Oct 21
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
9:00am
424B5
7vskn
14 Oct 21
Prospectus supplement for primary offering
8:31am
424B5
gi692ff3zej
13 Oct 21
Prospectus supplement for primary offering
12:00am
8-K
i7h8w
4 Oct 21
Other Events
4:48pm
8-K
xtx7u8ptzfza
7 Sep 21
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode
4:28pm
8-K
j2ib6oq3
13 Aug 21
NeuroOne Reports Third Quarter Fiscal 2021 Financial Results and Corporate Update
8:05am
8-K
53tr fihip
24 Jun 21
Changes in Registrant's Certifying Accountant
4:15pm
EFFECT
q60pev 8zu3
15 Jun 21
Notice of effectiveness
12:15am
CORRESP
4r67 m282xn9co
10 Jun 21
Correspondence with SEC
12:00am
UPLOAD
maskkjkqpms
9 Jun 21
Letter from SEC
12:00am
8-K
zrp3x
8 Jun 21
Submission of Matters to a Vote of Security Holders
4:32pm
S-3
v632yx
4 Jun 21
Shelf registration
5:19pm
8-K
zml kr2udy
25 May 21
NeuroOne Announces Approval for Nasdaq Capital Market Listing;Trading Expected to Commence Tomorrow May 26th, 2021 Under the Symbol NMTC
5:20pm
CERT
nct0r64u 50wjq
25 May 21
Certification of approval for exchange listing
4:46pm
8-A12B
nczyrnxn 5y4
25 May 21
Registration of securities on exchange
8:31am
8-K
kmycv2l s2
31 Mar 21
NeuroOne Medical Technologies Corporation Announces Reverse Stock Split as Part of Uplisting Strategy to Major Exchange
9:13am
424B3
e8k22is
9 Mar 21
Prospectus supplement
9:01am